Accelerating the Future of Cell & Gene Therapy

At CytoNiche, we specialize in simplifying the complex world of CGT, especially mesenchymal stem/stromal cells (MSCs) to drive the success of therapeutic commercialization. Our solutions empower you to scale up production with cost-effective, high-quality cells, so that you can focus on what you do best —— developing transformative therapeutics. By optimizing access and affordability, we accelerate the timeline for bringing groundbreaking products to market.

See What Powers Us >

News & Events

More Latest News >

Sep 28,2025

The Senior Vice President of Danaher and Delegation Visited CytoNiche to Discuss New Future of Cell Therapy and Scalable Production

We look forward to continued collaboration and dialogue with visionary leaders like Danaher as we work together toward building a more sustainable global CGT ecosystem.